🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Recurrent RCA STEMI due to under expanded stent constrained by calcium. Vessel size 4.5-5.0 mm. Tried 4.5 mm Shockwave Medical IVL and 4.5 NC to 24 ATM. No luck. Used 4.5 x 20 mm SIS Medical OPN🎈up to 40 ATM and it finally expanded. Avoided CABG…for now 👍🏼 #ACCFIT #CardioTwitter

Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association - Journal of Clinical Lipidology National Lipid Association lipidjournal.com/article/S1933-…

The Acropolis of Athens ✨

Role of apoB in Clinical Management infographic. Via National Lipid Association Journal of Clinical Lipidology

Surreal and somber flight into🗽NYC 🍎 on September 11th 🙏🏼 City of New York LaGuardia Airport NY Endovascular Summit #september11th

High lipoprotein(a) [(Lp(a)] is a genetically determined, important risk factor for cardiovascular disease that should be (but isn't) routinely measured (at least once). There are 5 drugs that look highly effective for markedly lowering levels in clinical trials. This new

I’m hearing so many people cite conflict of interest as the reason physicians shouldn’t own hospitals. This also happens to be the main strategy the American Hospital Association used to lobby Congress to ban POHs in the Affordable Care Act, paving the way for the consolidated

1/2 SCAI Mechanical Circulatory Support e-Book (🔗 scaipro.scai.org/URL/MCS-EBook): an awesome brand new addition to the “trilogy” (SCAI Vascular Management and SCCM Cardiac ICU e-Books): all 3 Free and Online (all 3 links in 2nd Tweet below👇)💥🫀⚡️…

2/2 👍Links to all 3 e-Books right here👉: #1 🔗 scaipro.scai.org/URL/MCS-EBook, #2 🔗 scaipro.scai.org/URL/VascularAc…, and #3 🔗 sccm.org/Education-Cent…⚡️🫀💥…

📢 SCAI releases 🆕 eBook on ‘Short-Term MCS for Cardiogenic Shock’ 💡#CardiogenicShock Fundamentals 💡Basics of #MCS 💡In-Depth Device Reviews 💡Device Selection & Combinations 💡Future Innovations 📚Read now: ow.ly/9VbB50TJUl4 Adhir Shroff Alex Truesdell Duane Pinto MD MPH

For all cardiology fellows — this is a great book that is free to learn about MCS for cardiogenic shock! Adhir Shroff Chad Morreale, DO Sandeep Nathan, MD, MSc Poonam Velagapudi Allison Dupont, MD Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI Anthony Teta, MD Jason Kaplan

Among patients with asymptomatic severe aortic stenosis, early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes. Full EARLY TAVR trial results: nej.md/4hjJZRc #TCT2024

Transcatheter Cardiovascular Therapeutics Conference Washington, DC #TCT2024

Download SCAI’s latest ebook today on #CardiogenicShock and #MechanicalCirculatorySupport. The ebook covers the essentials, including introductory concepts to device selection and future trends in the field. Learn practical tips to enhance patient outcomes. 💡Section 1: Intro to

Learn about the unique role of Lp(a) as a genetic determinant for #ASCVD risk & the importance of testing for Lp(a) levels to better understand your patients’ cardiovascular health w/ ACC's online course. ⬇️ More: bit.ly/3WmPipH #LpaAwarenessDay #KnowLpa #ACCEd

The KETO-CTA Study: Peeling Back A Layer 🥓🫀 It's been a wild 2-weeks. We've just been told this wasn't "the paper", despite 10 days of promoting and defending it?! In this video, I run through events, comments, and criticisms offered so far. Who knows what's next... #LMHR

Celebrating 5K TAVR at #AuroraStLukes - largest program in Wisconsin! Congratulations to the wonderful team and so many that have contributed throughout the years! 🎊🥳🔥💪🙏

SCAI wants lead-free cath labs and a better work-life balance for cardiologists ⁦Poonam Velagapudi⁩ ⁦Aditya Bharadwaj⁩ ⁦Giorgio A. Medranda MD, FACC, FAHA, FSCAI⁩ ⁦MIЯVΛƬ #IC⁩ ⁦Cardiovascular Business⁩ ⁦SCAI⁩⁩ ⁦David J. Cohen, MD, MSc⁩ ⁦Ankur Kalra⁩ cardiovascularbusiness.com/topics/clinica…

When it rains, it pours - More OBI data. Across 3 phase 3 trials, BROADWAY (obi), BROOKLYN (obi) & TANDEM (obi + ezetimibe), obicetrapib, an oral CETP inhibitor, effectively reduced not only LDL-C, but also Lp(a), especially in those with moderately elevated Lp(a) levels. In

Congratulations to the class of 2025! 🥳🎊🎂🔥 Proud of your accomplishments and hard work! Congratulations to all the mentors, faculty and family that made this happen. Couldn't have done it without your support! Suhail Allaqaband Patrycja Galazka Fuad Jan